United States · 
Who invested in Reprieve Cardiovascular?
Reprieve Cardiovascular's investors include Deerfield.
United States · Series B startup
Who invested in Reprieve Cardiovascular
Funding summaryUpdated 26 Oct 2026
$61Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $61MAug 2025
- Investors
- 1
The rounds
- Aug 2025
Founders and team
From Reprieve Cardiovascular's own website: 1 founder, 13 on the team.
- Mark PacynaChief Executive Officer
- Andrew HalpertVice President of R&D
- Annemarie ForrestVice President of Clinical Affairs
- Cassie MorrisVice President of Strategy and Innovation
- Adam BartnikChief Financial Officer
- Tony FieldsChief Operating Officer
- Don HefnerField Clinical Director
- Hanson GiffordPartner
- Jacob DavisDirector of Quality
- James EadieManaging Director
- Julien EspenonDirector, Europe
- Kenneth LuppiDirector of Operations
- Laura RudeenDirector of Clinical Affairs
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Reprieve Cardiovascular
How much has Reprieve Cardiovascular raised?
Reprieve Cardiovascular has raised $61M across 1 round since 2025.
When did Reprieve Cardiovascular last raise?
Reprieve Cardiovascular's most recent round was a Series B of $61M in Aug 2025.
What was Reprieve Cardiovascular's biggest round?
Its most recent round, $61M in Aug 2025, is also its largest on record.
Who backed Reprieve Cardiovascular first?
Reprieve Cardiovascular's first round on record, in Aug 2025, was backed by Deerfield.
What stage is Reprieve Cardiovascular at?
Reprieve Cardiovascular's latest named round is a Series B, in Aug 2025.
Where is Reprieve Cardiovascular based?
Reprieve Cardiovascular is based in the United States.
Companies like Reprieve Cardiovascular
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.